HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

sanggenone C

inhibits TNF-alpha-stimulated adhesion between polymorphonuclear lymphocytes and synovial cells; structure in first source

Also Known As:

cathayanon E; sanggenon C

Networked: 10 relevant articles (3 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        sanggenone C: 10
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        sanggenone C: 10
    - Benzofurans: 26
      - sanggenone C: 10

Experts

1.	Zhou, Ping: 2 articles (09/2017 - 01/2011)
2.	Xu, Jingfeng: 1 article (08/2020)
3.	Zhao, Yilei: 1 article (08/2020)
4.	Chen, Lin: 1 article (09/2018)
5.	Feng, Tingting: 1 article (09/2018)
6.	Guo, Donggui: 1 article (09/2018)
7.	Wang, Huijuan: 1 article (09/2018)
8.	Zhang, Min: 1 article (09/2018)
9.	Zhou, Ying: 1 article (09/2018)
10.	Chen, Yang: 1 article (10/2017)

Related Diseases

1.	Inflammation (Inflammations) 08/01/2020 - "Sanggenon C Ameliorates Cerebral Ischemia-Reperfusion Injury by Inhibiting Inflammation and Oxidative Stress through Regulating RhoA-ROCK Signaling." 10/01/2017 - "The effects of Sanggenon C on oxidative stress and inflammation have previously been reported; however, little is currently known regarding the effects of Sanggenon C on cardiac hypertrophy and fibrosis. "
2.	Reperfusion Injury 08/01/2020 - "Sanggenon C Ameliorates Cerebral Ischemia-Reperfusion Injury by Inhibiting Inflammation and Oxidative Stress through Regulating RhoA-ROCK Signaling."
3.	Osteoporosis 09/13/2018 - "Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model."
4.	Cardiomegaly (Heart Hypertrophy) 10/01/2017 - "After 4 weeks of AB, vehicle‑treated mice exhibited cardiac hypertrophy, fibrosis, and deteriorated systolic and diastolic function, whereas treatment with 10 and 20 mg/kg Sanggenon C treatment ameliorated these alterations, as evidenced by attenuated cardiac hypertrophy and fibrosis, and preserved cardiac function. " 10/01/2017 - "Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway." 10/01/2017 - "The effects of Sanggenon C on oxidative stress and inflammation have previously been reported; however, little is currently known regarding the effects of Sanggenon C on cardiac hypertrophy and fibrosis. " 10/01/2017 - "These results suggest that Sanggenon C may exert protective effects against cardiac hypertrophy and fibrosis via suppression of the calcineurin/NFAT2 pathway."
5.	Fibrosis (Cirrhosis) 10/01/2017 - "After 4 weeks of AB, vehicle‑treated mice exhibited cardiac hypertrophy, fibrosis, and deteriorated systolic and diastolic function, whereas treatment with 10 and 20 mg/kg Sanggenon C treatment ameliorated these alterations, as evidenced by attenuated cardiac hypertrophy and fibrosis, and preserved cardiac function. " 10/01/2017 - "The effects of Sanggenon C on oxidative stress and inflammation have previously been reported; however, little is currently known regarding the effects of Sanggenon C on cardiac hypertrophy and fibrosis. " 10/01/2017 - "These results suggest that Sanggenon C may exert protective effects against cardiac hypertrophy and fibrosis via suppression of the calcineurin/NFAT2 pathway."

Related Drugs and Biologics

1.	Calcineurin
2.	Prednisone (Sone)
3.	Flavonoids
4.	Ubiquitinated Proteins
5.	Caspase 9
6.	Caspase 3 (Caspase-3)
7.	TNF Receptor-Associated Factor 2 (TRAF2)
8.	Proteasome Endopeptidase Complex (Proteasome)
9.	Proteins (Proteins, Gene)
10.	Chymotrypsin